ViewRay highlights presentation at ESTRO 2022

By AuntMinnieEurope.com staff writers

May 10, 2022 -- Image-guided radiation therapy ViewRay is highlighting research presented at this week's annual meeting of the European Society for Radiotherapy and Oncology (ESTRO) in Copenhagen involving its MRIdian stereotactic MRI-guided radiation therapy (SMART) technology.

In a retrospective analysis, researchers from the Moffitt Cancer Center in Tampa, FL, reported that the treatment margins enabled by adaptation, real-time tracking, and automated beam control on MRIdian SMART may enable ablative radiation to be performed with minimal toxicity in hard-to-treat, metastatic, primary ultracentral and central lung lesions, according to the vendor.


Copyright © 2022 AuntMinnieEurope.com
 

To read this and get access to all of the exclusive content on AuntMinnieEurope.com create a free account or sign-in now.

Member Sign In:
MemberID or Email Address:  
Do you have a AuntMinnieEurope.com password?
No, I want a free membership.
Yes, I have a password:  
Forgot your password?
Sign in using your social networking account:
Sign in using your social networking
account: